• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Step Therapy Requirements Are Worsening, Says Dr James Howard

Video

Myasthenia gravis expert James F. Howard, Jr, MD, professor of neurology at the University of North Carolina at Chapel Hill, explains the burdens that step therapy places on patients with rare diseases and their providers.

James F. Howard, Jr, MD, professor of neurology at the University of North Carolina at Chapel Hill, former chief of the Neuromuscular Disorders Division, and former James F. Howard Distinguished Professor of Neuromuscular Disease, explains the step therapy burdens faced by patients with myasthenia gravis, as well as their providers.

Transcript

How are patients with rare diseases like myasthenia gravis affected by step therapy and prior authorization, and do you see this getting better or worse?

The burdens that are placed on to us by our payers through prior authorizations, etc, are overly burdensome. It consumes time—not only the physician, but of the staff—to complete paperwork, to spend countless amounts of time on telephone calls that totally detracts from our ability to provide top-level care to the individual patient themselves. I foresee this, unless there's a change in culture, in our legislature, I see this becoming progressively worse. And it has been over my career.

Related Videos
Phaedra Corso, PhD, associate vice president for research at Indiana University
"Integrating New PAH Therapies into Clinical Practice"
Julie Patterson, PharmD, PhD
"Clinical Evidence for Emerging PAH Therapies"
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Dr Chris Pagnani
Screenshot of Angela Jia, MD, PhD, during a video interview
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Screenshot of Alexander Kutikov, MD, during a video interview
Screenshot of Mary Dunn, MSN, NP-C, OCN, RN, during a video interview
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.